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Received March 4, 2014; accepted May 29, 2014AbstractThe retina, histologically composed of ten delicate layers, is responsible for light perception and relaying electrochemical signals to the
secondary neurons and visual cortex. Retinal disease is one of the leading clinical causes of severe vision loss, including age-related macular
degeneration, Stargardt's disease, and retinitis pigmentosa. As a result of the discovery of various somatic stem cells, advances in exploring the
identities of embryonic stem cells, and the development of induced pluripotent stem cells, cell transplantation treatment for retinal diseases is
currently attracting much attention. The sources of stem cells for retinal regeneration include endogenous retinal stem cells (e.g., neuronal stem
cells, Mu¨ller cells, and retinal stem cells from the ciliary marginal zone) and exogenous stem cells (e.g., bone mesenchymal stem cells, adipose-
derived stem cells, embryonic stem cells, and induced pluripotent stem cells). The success of cell transplantation treatment depends mainly on
the cell source, the timing of cell harvesting, the protocol of cell induction/transplantation, and the microenvironment of the recipient's retina.
This review summarizes the different sources of stem cells for regeneration treatment in retinal diseases and surveys the more recent
achievements in animal studies and clinical trials. Future directions and challenges in stem cell transplantation are also discussed.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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The eyes are a specialized sense organ extending from the
central nervous system that receives light stimulation at retinal
photoreceptor cells and relays electrochemical signals to the
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1726-4901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Assinnermost receptors of the eyes passes through several ocular
tissues, including transparent corneal tissues, aqueous humor,
the pupil, the lens, the vitreous layer, and ten layers of retinal
tissue. After the photoreceptor cells in the outer retina perceive
light, chemical energy is converted into electrical impulses
and is then transmitted to the brain through the axons of
ganglion cells occurring in the inner retina as bundles of nerve
fibers.
The retina is comprised of ten histological layers in the
following sequence: inner limiting membrane; nerve fiber
layer; ganglion cell layer; inner plexiform layer; inner nuclear
layer; outer plexiform layer; outer nuclear layer; external
limiting membrane; photoreceptor layer; and retinal pigmentociation. All rights reserved.
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of the bipolar cells, horizontal cells, and amacrine cells as well
as Mu¨ller cells; the outer nuclear layer contains the cell bodies
of rods and cones. The inner plexiform layer comprises the
synapse between the ganglion cell layer and the inner nuclear
layer; the outer plexiform layer contains the synapse between
the inner and the outer nuclear layers. At the cellular level the
retina consists of six classes of distinct neurons (cone and rod
photoreceptors, horizontal, bipolar, amacrine and ganglion
cells, Mu¨ller glial cells, and astrocytes) responsible for light
perception, signal integration, and tissue support/repair,
respectively.
Retinal regeneration after neuronal injury takes place in
several species of vertebrate, including fish, amphibians, birds,
and mammals. It has been assumed that retinal stem cells
(RSCs) or precursor cells are situated in the ciliary marginal
zone (CMZ), from which the rod precursors or Mu¨ller glial
cells may be recruited for retinal regeneration. As an extreme
example, retinal regeneration in teleost fish can occur even
after surgical removal of a portion of the central retina.
However, intrinsic retinal regeneration, occurring in fish and
chick embryos by the formation of new retinal neurons from
progenitor or stem cells in the CMZ, does not occur in
mammals, including humans.1,2 By contrast, mammalian
Mu¨ller glia proliferate and give rise to neuronal cells in
response to retinal damage, but the regenerative capacity is
more limited than that in fish and birds.3
In humans, neural stem cells and progenitor cells that
maintain their extended passage in vitro have been identified in
the brain, spinal cord, and fetal retina.4e8 Human retinal
progenitor cells isolated from the fetal retina are capable of
dividing for multiple generations and differentiating to several
retinal cell phenotypes, indicating that these cells have the
potential to be used therapeutically to replace damaged retinal
neurons. However, the availability of fetal retinas and associ-
ated ethical concerns may limit the extensive use of embryonic
stem cells (ESCs) in treating retinal diseases.
RSCs have been assumed to be in the pigmented or non-
pigmented epithelial layer of the ciliary margin at the pe-
ripheral edge of the retina. As most of the differentiated lin-
eages are photoreceptor cells, transplantation of RSCs has
shown potential as a tool for cell treatment in degenerative
retinal diseases.1 In this paper we review the different sources
of retinal and somatic stem cells and the current trends in
applying these versatile stem cells to cell transplantation.
2. Endogenous retinal stem cells
A population of retinal stem cells in the ciliary body of
mouse and human eyes has been identified as possessing the
ability to proliferate in vitro and produce all of the retinal cell
types.7,9,10 However, other evidence has shown that these
cultured retinal stem cells from the ciliary body are actually
RPE cells and lack the ability to generate the differentiated
retinal lineages, particularly photoreceptor cells.11,12 However,
RSCs harvested from porcine and murine retinas have been
shown to restore visual functions after allogeneic retinaltransplantation,13 thus the real properties of these cells still
need to be clarified.2.1. Neural stem cellsThe adult mammalian central nervous system contains
endogenous neural stem cells (NSCs) capable of proliferation
and further differentiation. The partially differentiated pro-
genitor populations isolated from the eye or the brain may be a
potential source for retinal cell transplantation. Our previous
study compared the proliferation and differentiation ability of
RSCs and NSCs, showing that the latter had a higher prolif-
erating potential at the 10th week, in contrast with RSCs,
which showed interrupted proliferation at the 8th week.14 We
also found that the combination of transforming growth factor
beta type III with retinoic acid played an important role in the
induction of NSCs to differentiate into opsin-positive cells.
The cells integrated into the outer retinal layer will usually
generate mature photoreceptor cells based on the cellular
morphology, expression of photoreceptor markers, and func-
tional recovery.2.2. Mu¨ller cellsMu¨ller cells are the major type of glial cells in the retina
and are responsible for the homeostatic and metabolic support
of retinal neurons. These cells are located across the entire
retinal layer, from the vitreous surface to the subretinal space.
Their function is thought to be the mediation of transcellular
ion, water, and bicarbonate transport.15 However, the exact
functions of Mu¨ller cells remain unknown. Mu¨ller cells
functioning as retinal stem cells in mammalian eyes have been
reported previously.15 Subsets of Mu¨ller cells from mature
retinas have been found with the properties of neural pro-
genitor or stem cells.16
Mu¨ller cells in zebra fish present the multipotent progenitor
marker, Pax6,17,18 and can be induced to dedifferentiate,
proliferate, and generate neural stem cells that migrate to
damaged retinas and further differentiate into neurons in
response to injury.19 Mu¨ller cells from zebra fish also play an
essential role in retinal growth, even in adulthood.18 In a study
of chicks, it was found that injury to the retina induced Mu¨ller
cells to re-enter the cell cycle and produce neurofilaments and
transcription factors which could only be found with an em-
bryonic status.20 Mu¨ller cells from the retina of chicks have
the potential to regenerate all types of retinal neuron in
response to injury, but this potential decreases with the age of
the animal.21 Karl et al22 found in vivo evidence that Mu¨ller
cells have the potential to proliferate and differentiate into new
neurons in the damaged retina of mice.
As a result of their potential to generate neuron stem cells,
Mu¨ller cells have been regarded as a potential cell-based
strategy for retinal regeneration. Some studies have shown
that transdifferentiated Mu¨ller cells could be cultured from
NSC markers expressing Mu¨ller cells extracted from mature
human retina, the epiretinal membrane of proliferative vitre-
oretinopathy patients, and human retinal cell lines.23e26
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injection can lead Mu¨ller cells to migrate into the retinal pa-
renchyma and express neuronal cell markers.232.3. Pigmented ciliary marginal zoneThe two cuboidal epithelia of the ciliary body derived from
the neural tube consist of the outer pigmented layer, contin-
uous with the RPE, and the inner nonpigmented layer, or
nonpigmented epithelium, continuous with the neural retina.27
The ciliary marginal zone (CMZ) is a ring of cells at the pe-
riphery of the maturing and matured neural retina that contains
RSCs and progenitor cells. Retinal neurons are added to the
periphery of the retina by differentiation of these non-
pigmented CMZ RSCs and associated progenitor cells. The
ciliary body is anteriorly adjacent to the CMZ and parts of it,
as well as the retina and CMZ, are derived from the optic cup.
Tropepe et al7 detected the presence of retinal stem cells in
the pigmented ciliary margin of the eyes of adult mice. These
cells show the multipotency of proliferation and self-renewal,
and can differentiate into bipolar neurons, Mu¨ller glia, and
photoreceptors. Liu et al14 showed that RSCs were also
localized in the pigmented ciliary margin of adult rats. These
RSCs have the potential for self-proliferation and multipotent
differentiation. Similar to RSCs found in the pigmented ciliary
margin of adult rodent eyes, pigmented cells at the retinal
margin of postnatal chicks were also noted to have the same
stem cell potential as those from embryonic retina.28
3. Potential of retinal differentiation from other somatic
stem cells3.1. Bone marrow mesenchymal stem cellsBone marrow mesenchymal stem cells (BMSCs) belong to
one of the established stem cell lines and the protocols for cell
purification, amplification, and transplantation are well
defined. The mechanism of repair in damaged tissue by
BMSCs was found via fusion with the host cells instead of
incorporation and transdifferentiation.29,30
Although BMSCs have the potential to rescue damaged
retinas, only a small portion of transplanted cells may integrate
into the host retina, while the rest remain in the vitreous cavity
without engrafting because of glia reactivity.31 To promote the
stem cell mediated regeneration of RPE, there are three ap-
proaches to deliver BMSCs into targeted retina.32 The first is
the endogenous delivery of BMSCs combined with pharma-
cologically enhanced growth factor mediated mobilization,
leading to the migration of cells into the subretinal space.33
Second, the transplantation can be accomplished by an exog-
enous approach. The third approach is subretinal injection;
BMSCs injected into the subretinal space may be integrated
into the RPE layer and express differentiation markers.
BMSCs can differentiate into neural precursor cells (nestin-
positive) and mature neurons (MAP-2 and Tuj1-positive)
following treatment with neural selection and induction
media. Furthermore, BMSC applications are not limited torepairing damaged RPE cells; our recent results showed that
BMSCs can have multipotential differentiation and differen-
tiate into photoreceptors and retinal cells after co-culture with
RPE cells. This platform provides us an ex vivo expansion
model of culturing photoreceptors for the treatment of retinal
degeneration diseases.343.2. Adipose-derived stem cellsAdipose tissue has been viewed as another source of stem
cells with several advantages. First, adipose-derived stem cells
(ASCs) are easily acquired in huge volumes via a relatively
pain-free, smooth approach. Second, ASCs can be repeatedly
harvested under local anesthesia.35 Third, ASCs show better
proliferation potential, are more easily separated by enzymes,
and have a longer life span than BMSCs.36 Currently, ASCs
are widely used for cosmetic purposes, such as breast recon-
struction, with relatively few safety concerns compared with
other sources of stem cells.
Applications of ASCs in ophthalmology are still in prog-
ress. According to some studies, ASCs may be induced to
differentiate into corneal epithelial-like phenotype, keratocyte,
and even retinal progenitor cells.37e39 ASCs have been found
to indirectly protect light-induced retinal injury through their
conditioned medium without cell transplantation, suggesting
that ASCs help to protect the retina from damage via secreted
proteins.40
4. Embryonic stem cells and induced pluripotent stem
cells
ESCs derived from the inner cell mass during the blastocyst
stage of embryos are capable of self-renewal indefinitely and
remain pluripotent to generate all the specialized cell types,
which have been shown to be valuable as donor cells for
retinal regeneration.41e43 However, ESC-based regeneration
treatment is restricted by the ethical issues of using human
embryos and the possibility of immune rejection after ESC
transplantation.
Similar to the properties of ESCs, it has been found that
induced pluripotent stem cells (iPSCs) can be induced from
somatic cells with the introduction of four transcription fac-
tors, namely Oct-3/4, Sox2, c-Myc, and Klf4.44 iPSCs present
many characteristics equivalent to those of ESCs, such as cell
morphology, proliferative abilities, surface antigens, gene ex-
pressions, the epigenetic status of pluripotent cell-specific
genes, telomerase activity, and teratoma formation.45,46
iPSCs can differentiate into cell types of three germ layers
that have enormous therapeutic potential for regenerative
medicine.47
Concerning the possibility of tumorigenicity, the introduc-
tion of four transcription factors, including c-Myc, is thought
to reactivate the c-Myc virus by overstimulating cell growth
and metabolism and/or by causing genomic instability.48
Dysregulated c-Myc expression is associated with several
human cancers and is often linked with a poor prognosis.49 An
earlier study successfully generated iPSCs from mouse and
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Oct-4, SOX2, and Klf4,without c-Myc. Mice treated with the
iPSCs without c-Myc (non-c-Myc iPSCs) did not develop tu-
mors during the study period.50 Our recent study reported that
subretinal transplantation of non-c-Myc iPSCs effectively
reduced retinal ischemia and reperfusion injury in a rat model
via the regulation of oxidative parameters and the paracrinal
secretion of trophic factors.51
5. Transplantation of stem cells
Treatment based on stem cells mainly depends on the
pathogenesis of the disease and the cell resources available for
transplantation. In previous reports, a retina with photore-
ceptor degeneration could be repaired by the transplantation of
photoreceptor precursors or ESC-derived progenitors, which
were able to form synaptic connections with the host retina
and improve visual function.52,53 In addition, the trans-
plantation of ESC-derived RPE has been reported to improve
visual function in RPE degeneration diseases, such as pre-
vailing age-related macular degeneration (AMD).54,55 John
et al2 summarized the choices of cell in regeneration treatment
for AMD. In Grade I AMD with only RPE degeneration,
transplantation of RPE alone is preferred. In Grade II AMD
with RPE and photoreceptor damage, BMSCs, with their
ability to differentiate into photoreceptors, have been sug-
gested. However, BMSCs are avoided in the treatment of wet
AMD because of their angiogenic potential. Instead, some
workers have successfully transplanted photoreceptor pre-
cursors into rod-deficient mice or mice with inherited photo-
receptor degeneration.56,57 In Grade III AMD involving the
RPE, photoreceptors, and retinal neurons, BMSCs, ESCs, and
iPSCs are all possible choices for transplantation based on
their ability to be induced and differentiated into retinal neu-
rons. There are currently two clinical trials on the subretinal
transplantation of ESC-derived RPE to confirm the safety and
tolerability of this technique in Stargardt's disease and patients
with dry AMD. However, ethical concerns and immune
rejection problems remain major issues with regard to these
cell sources. Some studies have shown that iPSCs could
promisingly restore retinal structure and function in mice with
retinal degeneration.58
The application of human pluripotent stem cells as a donor
cell source for transplantation treatment requires well-defined
and controlled differentiation conditions. Unlike somatic stem
cells with limited propagates, in theory ESCs and iPSCs have
the ability self-renew indefinitely. If photoreceptors and/or
RPE can be differentiated from human ESCs and iPSCs under
well-defined conditions without safety concerns, they will
have great potential for the repair of retinal degeneration.
The correct cell type and timing for harvesting donor cells is
critical for successful transplantation. For instance, one study
has shown that the integration of donor rod photoreceptors into
the host retina requires the rod photoreceptors to be taken from
the developing retina at a time coinciding with the peak of rod
genesis.53 These studies suggested that the ontogenic-staged
transplanted photoreceptors could integrate, differentiate intorod photoreceptors, form synaptic connections, and improve
visual function, further demonstrating the importance of cell
type-specific and stage-specific purification of the differenti-
ated ES and/or iPS cells. The selection of specific types of
ESC-derived progenitors for transplantation into host mice
relies on the identification of surface antigens coding rod
photoreceptors on postnatal Days 3e6 and the purification of
ES and iPS cell-derived rod photoreceptors corresponding to
the postnatal stage of Days 3e6.59 The host environment is
also crucial for successful photoreceptor transplantation.60
Retinal degeneration is well known, together with the
corresponding microglial activation and glial scar formation
that impedes the integration and survival of transplanted cells.
The robust integration of transplanted retinal cells into the
retinas of host mice without the assistance of both vimentin
and glial fibrillary acidic protein has been reported.61 More-
over, matrix metalloproteases and chondroitinases that
degrade the extracellular matrix in the diseased retina assist in
the integration of transplanted photoreceptors.62,63 The
disruption of the outer limiting membrane also increases
photoreceptor integration following transplantation.64 These
studies show that the glial barrier in the host retina prevents
the integration of donor photoreceptors. Therefore, in addition
to immunosuppression, the host retinal environment must also
be modulated for successful transplantation.65
Although evidence has shown that stem cells are capable of
differentiation into specialized tissues under certain condi-
tions, the question of how to apply these techniques into actual
regenerative medicine is still open. Such studies are important
to establish: (1) the principles of cell replacement treatment;
(2) that the recipient retina is indeed receptive to cells from an
external source; and (3) that the retinal microenvironment can
support and maintain foreign cells under certain conditions.
Immunological and tumorigenic concerns limit the therapeutic
use of ESCs. Although BMSCs are free from ethical concerns,
they are usually only available in very limited amounts and are
difficult to harvest. ASCs provide future potential for regen-
eration treatment that has so far received scant study. iPSCs
are an alternative route to maintain cells that are undifferen-
tiated for prolonged periods of time, to expand cell numbers,
to promote differentiation along a desired lineage, and to avoid
tumorigenicity in future differentiation directions. However,
more efforts need to be made on disease-specific and patient-
tailored stem cell transplantation for retinal regeneration to
translate the technology of iPSCs into a clinical setting.
In conclusion, research in retinal stem cells is an excellent
approach to understanding how concepts and methods of
regeneration medicine can be safely and efficiently used in
treating retinal diseases. Although the vertebrate retina has,
over recent decades, been well characterized and proposed as a
good model for studying neurogenesis, clarification of the
detailed mechanisms involved in retinal regeneration and
efficient methods to control the differentiation of pluripotent
cells still requires further investigation. In this review, we have
discussed several potential cell sources for regeneration
treatment that have arisen from various mammalian reprog-
ramming studies in clinical settings (Fig. 1). Success in
Fig. 1. Cell sources for stem cell transplantation treatment of retinal diseases.
560 T.-C. Lin et al. / Journal of the Chinese Medical Association 77 (2014) 556e561generating the desired cell types by direct reprogramming may
benefit from the selection of proper cell sources, the correct
timing of the applications, and the nourishing microenviron-
ment on which the transplanted cells depend. All of these
efforts offer feasible and promising results for patients to take
advantage of retinal transplantation in the future.
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